A risk for non-sexual transmission of human papillomavirus?

Expert Review of Anti-Infective Therapy

Volumn 12, Issue 10, 2014, Pages 1165-1170

  Ryndock, Eric J ^a   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

capsid; disinfectant; HPV; transmission; virus

Indexed keywords

CAPSID PROTEIN; VIRUS DNA; DISINFECTANT AGENT;

DISINFECTION; GENETIC STABILITY; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; LIFE CYCLE; NONHUMAN; REVIEW; VERTICAL TRANSMISSION; VIRUS SURVIVAL; VIRUS TRANSMISSION; WART VIRUS; FEMALE; FOMITE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PHYSIOLOGY; PROCEDURES; TRANSMISSION; VIROLOGY;

DISINFECTANTS; DISINFECTION; FEMALE; FOMITES; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84907061565     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2014.959497     Document Type: Review

References (62)

1. de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology 2004;324:17-27
2. Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 2004;68: 362-72
3. Gizzo S, Noventa M, Nardelli GB. Gardasil administration to hr-HPV-positive women and their partners. Trends Pharmacol Sci 2013;34:479-80
4. Zheng ZM, Baker CC. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 2006;11:2286-302
5. Meyers C, Frattini MG, Hudson JB, Laimins LA. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992;257:971-3
6. Roberts S, Ashmole I, Gibson LJ, et al. Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells. J Virol 1994;68: 6432-45
7. Bedell MA, Hudson JB, Golub TR, et al. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol 1991;65:2254-60
8. Madsen BS, Jensen HL, van den Brule AJ, et al. Risk factors for invasive squamous cell carcinoma of the vulva and vagina-population-based case-control study in Denmark. Int J Cancer 2008;122:2827-34
9. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56
10. Conway MJ, Alam S, Christensen ND, Meyers C. Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines. Virology 2009;393:295-303
11. Conway MJ, Cruz L, Alam S, et al. Differentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16. PLoS One 2011;6: e22427
12. Conway MJ, Alam S, Ryndock EJ, et al. Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J Virol 2009;83:10515-26
13. Conway MJ, Meyers C. Replication and assembly of human papillomaviruses. J Dent Res 2009;88:307-17
14. Hummel M, Hudson JB, Laimins LA. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol 1992;66:6070-80
15. Grassmann K, Rapp B, Maschek H, et al. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J Virol 1996;70:2339-49
16. Ozbun MA, Meyers C. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J Virol 1997;71: 5161-72
17. Joshi A, Nagashima K, Freed EO. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation. J Virol 2006;80:7939-51
18. Perez-Berna AJ, Ortega-Esteban A, Menendez-Conejero R, et al. The role of capsid maturation on adenovirus priming for sequential uncoating. J Biol Chem 2012;287:31582-95
19. Buck CB, Thompson CD, Pang YY, et al. Maturation of papillomavirus capsids. J Virol 2005;79:2839-46
20. Hanslip SJ, Zaccai NR, Middelberg AP, Falconer RJ. Intrinsic fluorescence as an analytical probe of virus-like particle assembly and maturation. Biochem Biophys Res Commun 2008;375:351-5
21. Ishii Y, Tanaka K, Kanda T. Mutational analysis of human papillomavirus type 16 major capsid protein L1: the cysteines affecting the intermolecular bonding and structure of L1-capsids. Virology 2003;308:128-36
22. Modis Y, Trus BL, Harrison SC. Atomic model of the papillomavirus capsid. EMBO J 2002;21:4754-62
23. Sapp M, Fligge C, Petzak I, et al. Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines. J Virol 1998;72:6186-9
24. Ryndock EJ, Conway MJ, Alam S, et al. Roles for human papillomavirus type 16 l1 cysteine residues 161, 229, and 379 in genome encapsidation and capsid stability. PLoS One 2014;9:e99488
25. Roden RB, Lowy DR, Schiller JT. Papillomavirus is resistant to desiccation. J Infect Dis 1997;176:1076-9
26. Rowson KE, Mahy BW. Human papova (wart) virus. Bacteriol Rev 1967;31:110-31
27. Alphs HH, Gambhira R, Karanam B, et al. Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. Proc Natl Acad Sci USA 2008;105:5850-5
28. Meyers J, Ryndock E, Conway MJ, et al. Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother 2014;69:1546-50
29. Chambon M, Archimbaud C, Bailly JL, et al. Virucidal efficacy of glutaraldehyde against enteroviruses is related to the location of lysine residues in exposed structures of the VP1 capsid protein. Appl Environ Microbiol 2004;70:1717-22
30. D'Souza DH, Su X. Efficacy of chemical treatments against murine norovirus, feline calicivirus, and MS2 bacteriophage. Foodborne Pathog Dis 2010;7:319-26
31. Eterpi M, McDonnell G, Thomas V. Disinfection efficacy against parvoviruses compared with reference viruses. J Hosp Infect 2009;73:64-70
32. Terpstra FG, van den Blink AE, Bos LM, et al. Resistance of surface-dried virus to common disinfection procedures. J Hosp Infect 2007;66:332-8
33. Tay SK, Ho TH, Lim-Tan SK. Is genital human papillomavirus infection always sexually transmitted? Aust N Z J Obstet Gynaecol 1990;30:240-2
34. Kjaer SK, Chackerian B, van den Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001;10:101-6
35. Jones V, Smith SJ, Omar HA. Nonsexual transmission of anogenital warts in children: a retrospective analysis. ScientificWorldJournal 2007;7:1896-9
36. Winer RL, Hughes JP, Feng Q, et al. Detection of genital HPV types in fingertip samples from newly sexually active female university students. Cancer Epidemiol Biomarkers Prev 2010;19:1682-5
37. Sonnex C, Strauss S, Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect 1999;75:317-19
38. Hahn HS, Kee MK, Kim HJ, et al. Distribution of maternal and infant human papillomavirus: risk factors associated with vertical transmission. Eur J Obstet Gynecol Reprod Biol 2013;169:202-6
39. Smith EM, Parker MA, Rubenstein LM, et al. Evidence for vertical transmission of HPV from mothers to infants. Infect Dis Obstet Gynecol 2010;2010:326369
40. Freitas AC, Mariz FC, Silva MA, Jesus AL. Human papillomavirus vertical transmission: review of current data. Clin Infect Dis 2013;56:1451-6
41. Park H, Lee SW, Lee IH, et al. Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery. Virol J 2012;9:80
42. Hong Y, Li SQ, Hu YL, Wang ZQ. Survey of human papillomavirus types and their vertical transmission in pregnant women. BMC Infect Dis 2013;13:109
43. Tenti P, Zappatore R, Migliora P, et al. Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol 1999;93:475-9
44. Weyn C, Thomas D, Jani J, et al. Evidence of human papillomavirus in the placenta. J Infect Dis 2011;203:341-3
45. Noventa M, Andrisani A, Gizzo S, et al. Is it time to shift the attention on early stages embryo development to avoid inconclusive evidence on HPV-related infertility: debate and proposal. Reprod Biol Endocrinol 2014;12:48
46. Berretta R, Gizzo S, Dall'Asta A, et al. Risk of preterm delivery associated with prior treatment of cervical precancerous lesion according to the depth of the cone. Dis Markers 2013;35:721-6
47. Saccardi C, Gizzo S, Noventa M, et al. High-risk human papillomavirus DNA test: could it be useful in low-grade cervical lesion triage? Five-year follow-up. Reprod Sci 2014;21:198-203
48. Shah KV. A case for immunization of human papillomavirus (HPV) 6/11-infected pregnant women with the quadrivalent HPV vaccine to prevent juvenile-onset laryngeal papilloma. J Infect Dis 2014;209: 1307-9
49. Chesson HW, Ekwueme DU, Saraiya M, et al. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine 2012;30:6016-19
50. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 2004;114:1-23
51. Derkay CS. Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg 1995;121:1386-91
52. Silverberg MJ, Thorsen P, Lindeberg H, et al. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 2003;101:645-52
53. Hignett M, Claman P. High rates of perforation are found in endovaginal ultrasound probe covers before and after oocyte retrieval for in vitro fertilization-embryo transfer. J Assist Reprod Genet 1995;12:606-9
54. Rooks VJ, Yancey MK, Elg SA, Brueske L. Comparison of probe sheaths for endovaginal sonography. Obstet Gynecol 1996;87:27-9
55. Storment JM, Monga M, Blanco JD. Ineffectiveness of latex condoms in preventing contamination of the transvaginal ultrasound transducer head. South Med J 1997;90:206-8
56. Milki AA, Fisch JD. Vaginal ultrasound probe cover leakage: implications for patient care. Fertil Steril 1998;69:409-11
57. Casalegno JS, Le Bail Carval K, Eibach D, et al. High risk HPV contamination of endocavity vaginal ultrasound probes: an underestimated route of nosocomial infection? PLoS One 2012;7:e48137
58. Ma ST, Yeung AC, Chan PK, Graham CA. Transvaginal ultrasound probe contamination by the human papillomavirus in the emergency department. Emerg Med J 2013;30:472-5
59. M'Zali F, Bounizra C, Leroy S, et al. Persistence of microbial contamination on transvaginal ultrasound probes despite low-level disinfection procedure. PLoS One 2014;9:e93368
60. Kac G, Podglajen I, Si-Mohamed A, et al. Evaluation of ultraviolet C for disinfection of endocavitary ultrasound transducers persistently contaminated despite probe covers. Infect Control Hosp Epidemiol 2010;31:165-70
61. Stroncek JD, Reichert WM. Overview of wound healing in different tissue types. In: Reichert WM, editor. Indwelling neural implants strategies for contending with the in vivo environment. CRC Press; Boca Raton, FL, USA: 2008
62. Gizzo S, Ferrari B, Noventa M, et al. Male and couple fertility impairment due to HPV-DNA sperm infection: update on molecular mechanism and clinical impact-systematic review. Biomed Res Int 2014;2014:230263